Article
Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition.
Leukemia - 1 Jun 2015
Chen L, Chen W, Mysliwski M, Serio J, Ropa J, Abulwerdi F A, Chan R J, Patel J P, Tallman M S, Paietta E, Melnick A, Levine R L, Abdel-Wahab O, Nikolovska-Coleska Z, Muntean A G
Abstract excerpt
PTPN11 encodes the Shp2 non-receptor protein-tyrosine phosphatase implicated in several signaling pathways. Activating mutations in Shp2 are commonly associated with juvenile myelomonocytic leukemia but are not as well defined in other neoplasms. Here we report that Shp2 mutations occur in human acute myeloid leukemia (AML) at a rate of 6.6% (6/91) in the ECOG E1900 data set. We examined the role of mutated Shp2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
